When used under medical supervision, they may support steady, sustainable weight loss
No contraindication exists for concurrent use with anticoagulants including warfarin, DOACs (apixaban, rivaroxaban, edoxaban, dabigatran), or low-molecular-weight heparins
When Vyleesi was approved in 2019, an FDA official announced that it was evidence of the agencys commitment to protect and advance the health of women. But since then, female Viagra seems to have found an unexpected market: men
Many patients will not be candidates for this treatment, and that determination is made intentionally, not by default
Type 2 diabetes with chronic kidney disease or elevated inflammatory burden
In the spotlight Sally Rose - CA May 11, 2023